JP2010513300A5 - - Google Patents

Download PDF

Info

Publication number
JP2010513300A5
JP2010513300A5 JP2009541572A JP2009541572A JP2010513300A5 JP 2010513300 A5 JP2010513300 A5 JP 2010513300A5 JP 2009541572 A JP2009541572 A JP 2009541572A JP 2009541572 A JP2009541572 A JP 2009541572A JP 2010513300 A5 JP2010513300 A5 JP 2010513300A5
Authority
JP
Japan
Prior art keywords
obese patients
bmi
pharmaceutically acceptable
use according
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009541572A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010513300A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/087322 external-priority patent/WO2008074001A1/en
Publication of JP2010513300A publication Critical patent/JP2010513300A/ja
Publication of JP2010513300A5 publication Critical patent/JP2010513300A5/ja
Withdrawn legal-status Critical Current

Links

JP2009541572A 2006-12-15 2007-12-13 肥満患者における高血圧の予防および処置のためのレニン阻害剤 Withdrawn JP2010513300A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87018006P 2006-12-15 2006-12-15
PCT/US2007/087322 WO2008074001A1 (en) 2006-12-15 2007-12-13 Renin inhibitors for the prevention and treatment of hypertension in obese patients

Publications (2)

Publication Number Publication Date
JP2010513300A JP2010513300A (ja) 2010-04-30
JP2010513300A5 true JP2010513300A5 (cg-RX-API-DMAC7.html) 2011-02-03

Family

ID=39186152

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009541572A Withdrawn JP2010513300A (ja) 2006-12-15 2007-12-13 肥満患者における高血圧の予防および処置のためのレニン阻害剤

Country Status (18)

Country Link
US (1) US20100029775A1 (cg-RX-API-DMAC7.html)
EP (1) EP2094259A1 (cg-RX-API-DMAC7.html)
JP (1) JP2010513300A (cg-RX-API-DMAC7.html)
KR (1) KR20090090384A (cg-RX-API-DMAC7.html)
CN (1) CN101583355A (cg-RX-API-DMAC7.html)
AU (1) AU2007333095B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0721167A2 (cg-RX-API-DMAC7.html)
CA (1) CA2672579A1 (cg-RX-API-DMAC7.html)
CL (1) CL2007003628A1 (cg-RX-API-DMAC7.html)
IL (1) IL198876A0 (cg-RX-API-DMAC7.html)
MA (1) MA31003B1 (cg-RX-API-DMAC7.html)
MX (1) MX2009006340A (cg-RX-API-DMAC7.html)
NO (1) NO20092597L (cg-RX-API-DMAC7.html)
RU (1) RU2009126741A (cg-RX-API-DMAC7.html)
TN (1) TN2009000240A1 (cg-RX-API-DMAC7.html)
TW (1) TW200831071A (cg-RX-API-DMAC7.html)
WO (1) WO2008074001A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200903442B (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2143425A1 (de) * 2008-07-11 2010-01-13 Ratiopharm GmbH Direktverpresste Aliskiren-Tabletten

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8168616B1 (en) * 2000-11-17 2012-05-01 Novartis Ag Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
TW200538154A (en) * 2004-02-17 2005-12-01 Novartis Ag Combination of organic compounds
RU2426532C2 (ru) * 2004-03-17 2011-08-20 Новартис Аг Применение органических соединений
WO2007047351A2 (en) * 2005-10-13 2007-04-26 Orexigen Therapeutics, Inc. Methods for treating hypertension in overweight and obese individuals
CA2655144A1 (en) * 2006-06-15 2007-12-21 Gilead Colorado, Inc. Antihypertensive therapy method

Similar Documents

Publication Publication Date Title
Ferrario Role of angiotensin II in cardiovascular disease—therapeutic implications of more than a century of research
Atlas The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition
Seeland et al. Sex and gender differences in cardiovascular drug therapy
ME00479B (me) Lijek za profilaksu i tretman arterioskleroze i hipertenzije
KR20050008717A (ko) 레닌 억제제, 칼슘 채널 차단제 및 이뇨제를 포함하는약제학적 조성물
ZA200303497B (en) Synergistic combinations comprising a renin inhibitor for cardiovascular diseases.
DK3027183T3 (en) SELECTIVE AT2 RECEPTOR AGONISTS FOR USING CACKSY TREATMENT
JP2023546970A5 (cg-RX-API-DMAC7.html)
CA2214143A1 (en) Combination compositions containing benazepril or benazeprilat and valsartan
WO2001060370A1 (en) Remedies for endothelin-induced diseases
CN106163518B (zh) 包含血管紧张素-Ⅱ受体阻断剂和HMG-CoA还原酶抑制剂的药物组合制剂
EP1019048B1 (en) Use of an angiotensin ii receptor antagonist for the preparation of drugs to increase the survival rate of renal transplant patients
CN1187050C (zh) 内皮素拮抗剂和血管紧张肽原酶-血管紧张肽系统抑制剂的联合体系
Meredith Candesartan cilexetil–a review of effects on cardiovascular complications in hypertension and chronic heart failure
Van Zwieten Angiotensin II receptor antagonists (AT1-blockers, ARBs, sartans): similarities and differences
Kangussu et al. Beneficial effects of the angiotensin-converting enzyme 2 activator dize in renovascular hypertension
Verdecchia et al. Treatment strategies for osteoarthritis patients with pain and hypertension
Dodson Hypertension and diabetes
JPWO2011162390A1 (ja) 徐放性高血圧および腎機能障害治療剤
TW201000097A (en) Medicament for the prophylaxis or treament of hypertension
US20120088730A1 (en) Use of angiotensin converting enzyme (ace) domain specific inhibitors to inhibit or enhance cytokine production and alter immune response
Chaabouni et al. ALDOSTERONE IN POLYCYSTIC OVARY SYNDROME
WO2003007964A1 (en) Remedial or preventive agent for cardiopathy or aneurysm containing chymase inhibitory compound
CN110215455A (zh) 一种用于降血压的药物配方
Galceran et al. Renin Angiotensin System and Obesity-Related Organ Damage